ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the publication of ...

"The future looks bright as far as a cure," one top HIV cure researcher told LGBTQ Nation.

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders,* today announced final data from the LATITUDE phase III trial, confirming its ...

More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS). The ...

Explore the latest advancements in HIV therapy and how enhanced immune cells can improve treatment outcomes for patients.

While medical breakthroughs have made ending HIV transmission a realistic goal, experts warn that stigma and misinformation ...

Drug conjugates (ADCs) developed at Institute of Science Tokyo combine a CD4 mimic with neutralizing antibodies for enhanced suppression of human immunodeficiency virus (HIV) infection. By targeting ...

Scientists have also long focused on the gut as a central battleground in HIV: it is rich in immune tissue, it is where major immune disruption occurs early, and it can remain a reservoir for the ...

Florida's proposed rule change to its AIDS Drug Assistance Program could cut off over 16,000 Floridians from life-saving ...

The PROTAC market is experiencing rapid growth, driven by rising interest in targeted protein degradation as a next-generation therapeutic approach. Expanding oncology pipelines with drugs in clinical ...

Last weekend, communities nationwide marked Black HIV/AIDS Awareness Day, or NBHAAD, during an urgent time for people living with the disease and those who support them. More than four decades after ...

The Department of Health (DOH) on Saturday said more than 300 Human Immunodeficiency Virus (HIV) care facilities are now ...